Startups
Synteny
Synteny develops MANIFOLD, an AI and experimental biology platform for designing protein therapeutics. It combines sequence, structure and physics models with large-scale laboratory measurements of molecular binding to predict affinity, specificity and unwanted interactions, then tests AI-designed molecules in high-throughput assays. Its first therapeutic application is T-cell receptor T-cell engagers for solid tumours and immunology. The UK-headquartered company also has a US presence; these are research and drug-development programmes rather than marketed or approved treatments.
Team
Alex PowleslandHead of Discovery |
Andrei NicaHead of Autonomous AI |
Ben GreenbaumAdvisory Board Member |
Bridget MartellAdvisory Board Member |
Chris GibsonAdvisory Board Member |
Daniel FisherAdvisory Board Member |
Danny WellsAdvisory Board Member |
David MoodDirector, Strategy & Operations |
Dubravka Pezic KesslerPrincipal Scientist |
Geoffrey DuykAdvisory Board Member |
Guy DurantAI Research Scientist |
James DayHead of Engineering |
James KingAI Research Scientist |
Jamie BlundellCo-Founder & CSO |
Jennifer CarterBoard Director |
Josh MeyersProtein Engineering AI Lead |
Julien CornebiseAdvisory Board Member |
Kathy SeidlAdvisory Board Member |
Laurence ReidAdvisory Board Member |
Lilly WollmanCo-Founder & CEO; Board Director |
Lisa HintonChief of Staff |
Mehdi GhissassiAdvisory Board Member |
Neil DalchauHead of Computational Biology |
Pam CarrollAdvisory Board Member |
Robert VonderheideAdvisory Board Member |
Rohan GaneshBoard Director |
S R Gokul KrishnanEngineer |
Somayya ManzoorScientist II |
 Steve CrossanAdvisory Board Member |
Tudor BerariuPrincipal Research Scientist |
Victoria KoullourouScientist II |